Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,570,600
  • Shares Outstanding, K 56,573
  • Annual Sales, $ 1,891 M
  • Annual Income, $ 447,100 K
  • 60-Month Beta 1.09
  • Price/Sales 3.99
  • Price/Cash Flow 7.96
  • Price/Book 2.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 3.57
  • Number of Estimates 5
  • High Estimate 3.67
  • Low Estimate 3.34
  • Prior Year 3.27
  • Growth Rate Est. (year over year) +9.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
117.51 +17.81%
on 10/16/19
138.83 -0.28%
on 11/15/19
+20.39 (+17.27%)
since 10/15/19
3-Month
116.52 +18.81%
on 10/14/19
138.83 -0.28%
on 11/15/19
+7.05 (+5.37%)
since 08/15/19
52-Week
113.52 +21.95%
on 12/24/18
154.44 -10.36%
on 12/03/18
-5.22 (-3.63%)
since 11/15/18

Most Recent Stories

More News
Why Jazz (JAZZ) Might be Well Poised for a Surge

Jazz (JAZZ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

JAZZ : 138.64 (+3.60%)
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the marketing...

JAZZ : 138.64 (+3.60%)
Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at three upcoming investor conferences.

JAZZ : 138.64 (+3.60%)
Diverse Biotech announces appointment of new Chief Executive Officer (CEO) - Stella Vnook

Diverse Biotech, Inc. www.diversebiotech.com, has announced that Stella Vnook has assumed the newly created Chief Executive Officer role. She is an Industry veteran with more than 25 years' experience....

JAZZ : 138.64 (+3.60%)
MRK : 84.90 (+0.41%)
Zacks.com featured highlights include: Lithia, KB, Anixter, Navient and Jazz

Zacks.com featured highlights include: Lithia, KB, Anixter, Navient and Jazz

LAD : 160.86 (-0.20%)
KBH : 34.28 (-0.87%)
AXE : 86.20 (+0.83%)
NAVI : 14.26 (-0.70%)
JAZZ : 138.64 (+3.60%)
JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ : 138.64 (+3.60%)
ZTS : 117.92 (+1.44%)
Here is Why Growth Investors Should Buy Jazz (JAZZ) Now

Jazz (JAZZ) possesses solid growth attributes, which could help it handily outperform the market.

JAZZ : 138.64 (+3.60%)
Bet on These 5 High Earnings Yield Stocks to Book Profits

Check out these five high earnings yield stocks for a powerful portfolio.

LAD : 160.86 (-0.20%)
KBH : 34.28 (-0.87%)
AXE : 86.20 (+0.83%)
NAVI : 14.26 (-0.70%)
JAZZ : 138.64 (+3.60%)
Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

JAZZ : 138.64 (+3.60%)
Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 15 abstracts sponsored by Jazz Pharmaceuticals, including one oral presentation, one abstract from a collaboration trial with MD Anderson Cancer...

JAZZ : 138.64 (+3.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade JAZZ with:

Business Summary

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and...

See More

Key Turning Points

2nd Resistance Point 135.95
1st Resistance Point 134.89
Last Price 138.64
1st Support Level 132.38
2nd Support Level 130.93

See More

52-Week High 154.44
Fibonacci 61.8% 138.81
Last Price 138.64
Fibonacci 50% 133.98
Fibonacci 38.2% 129.15
52-Week Low 113.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar